Reaction of [(η4-COD)Ir(Cl)PR´3] (R´ = Ph, 1; Me, 2) with lithium(oxobutadienide) (4) and lithium(2,4-dimethyl-oxopentadienide) (5) affords the η3-oxopentadienyl [(η4-COD)Ir(η3-exo-syn-syn-CH2CHCHCHO)PPh3] (6), the alkenyl carbonyl [(η4-COD)Ir(η1-CHCHMe)(CO)PMe3] (7), and the 2,4-dimethyl-η3-oxopentadienyl [(η4-COD)Ir(η3-exo-syn-anti–CH2CMeCHCMeO)PPh3] (8), as well as the mixture of isomers [(η4-COD)Ir(η3-exo-syn-anti-CH2CMeCHCMeO)PMe3] (9a) and [(η4-COD)Ir(η3-exo-anti-anti-CH2CMeCHCMeO)PMe3] (9b) in a 2:1 ratio, respectively.The synthesis of azapentadienyl compounds obtained from the reaction of [(η4-COD)Ir(Cl)PR´3] (R = Ph, 1; Me, 2; i-Pr, 3) with lithium azapentadienide Li(CH2CHCHCHNR) showed the exclusive η3-exo-syn-syn coordination mode for the azapentadienyl ligands in [(η4-COD)Ir(η3-CH2CHCHCHNR)PR´3] (R = t-Bu, R´= Ph, 13; R´= Me, 14; R´= i-Pr, 15 and R = C6H11, R´= Ph, 16). Novel bridging azapentadienyl ligands in the dinuclear [(η4-COD)Ir(1-3:5-η-μ2-CH2CHCHCHNt-Bu)PMe3][IrCl(η4-COD)] (18) and the iridaazacyclohexadiene [(η4-COD)Ir[μ-(1,5:1-4-η-μ2-CHCHCH2CHNCy)]Ir(η4-COD)] (19) compounds were synthesized by the reaction of [(η4-COD)Ir(μ2-Cl)]2 (17) with 14 or lithium azapentadienide (11), respectively. All chiral heteropentadienyl complexes showed evidence for the lack of symmetry of the nonconjugated unsaturated cyclooctadiene ligands.Compounds 8, 9a, 13, 15, 18 and 19, as well as the side-product, 2-acetyl-1,3,3,5-tetramethyl-5-cyclohexen-1-ol (10), which result of the favorable cycloaddition reaction in the presence of lithium 2,4-dimethyl-oxopentadienide (5), have been structurally characterized by single-crystal X-ray diffraction studies. The parameters for all mononuclear heteropentadienyl crystalline structures show a geometric distorsion from square-pyramidal (SP), where the phosphine ligands are in the apical site, being the highest distorsion observed for the azapentadienyl complexes, compared to pentadienyl and oxopentadienyl analogues.